Showing results (2791-2800 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|September 22, 2026
Toxicity Attribution During Enfortumab Vedotin Plus Pembrolizumab Therapy in Urothelial Carcinoma: A Practical FrameworkJabra Zarka, Daniel S Childs, Miguel Muniz Rincon, et al.
The Oncologist|September 7, 2026
Apatinib monotherapy for pretreated advanced squamous cell carcinoma of the penis: a phase II trialJuan Zhou, Wenfeng Li, Mingjuan Sun, et al.
The Oncologist|September 15, 2026
Real-world treatment patterns and outcomes in metastatic clear cell renal cell carcinoma following immune checkpoint inhibitor progression (2018-2023)Neil J Shah, Rahul Ravilla, Andrew J Osterland, et al.
The Oncologist|October 5, 2026
Re-evaluating the Role of Adjuvant Chemotherapy after Neoadjuvant Therapy in Resected Gastric CancerAravind Sreeram, Celine Yeh, Nicolas Toumbacaris, et al.
The Oncologist|September 29, 2026
Real-world implementation of a decision aid for treatment decisions in metastatic pancreatic cancer: a prospective multicenter study across expert centersMerlijn U J E Graus, Thijmen H T Broekman, Sietske van Nassau, et al.
The Oncologist|October 6, 2026
Baseline 25-Hydroxyvitamin D and Progression-Free Survival in de novo mHSPC: Prognostic Model Development and External ValidationGalip Can Uyar, Kadriye Başkurt, Orhun Akdoğan, et al.
The Oncologist|October 16, 2026
Whole Genome Sequencing-based tumor-informed circulating tumor DNA monitoring for early detection of recurrence in patients with solid tumorsMridula George, Gary S Schwartz, Wassim McHayleh, et al.
The Oncologist|October 11, 2026
Reference frame for Adult Brainstem gliomasFlorence Laigle-Donadey, Emmanuel Mesny, Franck Bielle, et al.
The Oncologist|October 20, 2026
Long-term efficacy, clinical outcomes, and safety of vimseltinib in patients with tenosynovial giant cell tumor: results from the MOTION phase 3 trialVivek Bhadri, Hans Gelderblom, Silvia Stacchiotti, et al.
The Oncologist|October 20, 2026
Characteristics and Outcomes of NATALEE- and monarchE-Eligible Early Breast Cancer in Finland: A Regional Real-world Cohort StudySari Voutilainen, Samuli Tuominen, Liisa Ukkola-Vuoti, et al.
Pageof 571